📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Therapeutic gene editing of T cells to correct CTLA-4 insufficiency. (2022)

First Author: Fox TA

Attributed to: CD96 a new immunoregulatory molecule - molecular mechanisms funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1126/scitranslmed.abn5811

PubMed Identifier: 36288278

Publication URI: http://europepmc.org/abstract/MED/36288278

Type: Journal Article/Review

Volume: 14

Parent Publication: Science translational medicine

Issue: 668

ISSN: 1946-6234